Video Experimental Relacionado

Updated: Mar 7, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

Adicción transcripcional en el cáncer

James E Bradner¹, Denes Hnisz², Richard A Young³

¹Novartis Institutes for Biomedical Research, 181 Massachusetts Avenue, Cambridge, MA 02139, USA.

|February 11, 2017

Resumen

Las células cancerosas secuestran reguladores de la expresión génica debido a cambios genéticos. Comprender estas dependencias ofrece nuevos objetivos terapéuticos para el tratamiento del cáncer.

Área de la Ciencia:

Biología molecular
La genética
En el campo de la oncología

Sus antecedentes:

El cáncer se origina por alteraciones genéticas que conducen a programas de transcripción anormales.
Las células cancerosas a menudo desarrollan dependencias de reguladores específicos de la expresión génica.

Objetivo del estudio:

Explorar cómo los cambios genéticos interrumpen el control de la transcripción en el cáncer.
Para explicar el desarrollo de dependencias transcripcionales en las células cancerosas.
Para resaltar las oportunidades terapéuticas que surgen de estas dependencias.

Principales métodos:

Revisión de las alteraciones genéticas en el cáncer.
Análisis de los mecanismos de desregulación de la transcripción
Examen de las dependencias del regulador de la expresión génica.
Discusión de estrategias terapéuticas dirigidas a las dependencias transcripcionales.

Principales resultados:

Las alteraciones genéticas interrumpen el control transcripcional normal en el cáncer.
Los programas desregulados crean vulnerabilidades y dependencias de reguladores específicos.
Estas dependencias representan objetivos prometedores para nuevas terapias contra el cáncer.

Conclusiones:

Dirigirse a las dependencias transcripcionales específicas del cáncer ofrece una estrategia terapéutica viable.
Comprender la interacción entre las alteraciones genéticas y la expresión génica es crucial para desarrollar tratamientos efectivos contra el cáncer.

Más Videos Relacionados

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers

Published on: September 26, 2019

Videos de Conceptos Relacionados

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...